These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1435694)

  • 1. [Immunohistochemical detection of p53 in colorectal cancer and its relationship to prognosis].
    Yamaguchi A; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1992 Oct; 93(10):1312-6. PubMed ID: 1435694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of overexpression of P53 protein in colorectal carcinoma on short-term prognosis].
    Domínguez Iglesias F; Riera Velasco JR; Junco Petrement P; Tojo Ramallo P; Díaz-Faes Cervero M
    Rev Esp Enferm Dig; 1994 Nov; 86(5):796-802. PubMed ID: 7848689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
    J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis.
    Yamaguchi A; Kurosaka Y; Fushida S; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Cancer; 1992 Dec; 70(12):2778-84. PubMed ID: 1451055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study on the prognostic value of the nuclear expression of protein p53 vis-à-vis histopathology in colorectal cancer].
    Díez M; Camuñas J; Enríquez JM; González A; Torabuela E; Gutiérrez A; Ratia T; Mugüerza JM; Martín A; Ruiz A; Granell J
    An Med Interna; 1996 May; 13(5):222-6. PubMed ID: 8767868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An immunohistochemical study of the relationship between p53 expression and the DNA ploidy pattern using image cytometry in colorectal carcinoma].
    Miki T; Funahashi K; Tsujita K; Takatsuki M; Koike J; Kubota S; Goto T; Nagasawa Y; Kobayashi K; Yanagita K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():130-3. PubMed ID: 7611775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.
    Lashner BA; Bauer WM; Rybicki LA; Goldblum JR
    Am J Gastroenterol; 2003 Jun; 98(6):1423-7. PubMed ID: 12818291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
    Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression in colorectal tumors.
    Purdie CA; O'Grady J; Piris J; Wyllie AH; Bird CC
    Am J Pathol; 1991 Apr; 138(4):807-13. PubMed ID: 1707233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
    Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
    J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis is a new promising prognostic factor in colorectal cancer.
    Pollheimer MJ; Kornprat P; Lindtner RA; Harbaum L; Schlemmer A; Rehak P; Langner C
    Hum Pathol; 2010 Dec; 41(12):1749-57. PubMed ID: 20869096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of P53 and heat shock protein in colorectal tumors: an immunohistochemical study].
    Morimoto H; Monden T; Miyoshi Y; Kawasaki Y; Nakanishi H; Shimano T; Mori T
    Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1094-7. PubMed ID: 1944162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
    Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of cancer cell growth and apoptosis in morphogenesis of colorectal cancer].
    Seki H
    Hokkaido Igaku Zasshi; 2000 Sep; 75(5):325-34. PubMed ID: 11070793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.